drugset
drugset / Trial / NCT01286974

A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.

NCT01286974 ↗

Phase 1 Terminated 3 enrolled Abbott
Non-randomizedCrossoverOpen-labelBasic science

Summary

A pharmacokinetic study to access how the body absorbs and removes linifanib in male patients with advanced solid tumors.

Timeline

Start
2011-08
Primary completion
2012-08
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-869 Unknown — Oral

Indications

cancer